NCT03223519View on ClinicalTrials.gov

COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 12, 2017

Primary Completion Date

November 24, 2017

Study Completion Date

November 28, 2017

Conditions
Delayed Onset Muscle Soreness, DOMS
Interventions
DRUG

Comboprofen

Triple combination of Ibuprofen, Magnesium and Vitamin C Powder for oral solution administered TID for 3 days

DRUG

Placebo

Powder for oral solution administered TID for 3 days

DRUG

Ibuprofen

Powder for oral solution administered TID for 3 days

DRUG

Magnesium

Powder for oral solution administered TID for 3 days

DRUG

Vitamin C

Powder for oral solution administered TID for 3 days

Trial Locations (1)

08025

Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Barcelona

Sponsors

Lead Sponsor

Spherium Biomed
All Listed Sponsors
collaborator

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

lead

Spherium Biomed

INDUSTRY